IPOPLUS

₹162.48

▼ -0.16 -0.10%

18 Jun 2026

NSE Listed

Ind Swift Laboratories Limited (INDSWFTLAB)

Volume: 3,72,371Avg Vol 1W: 9,67,963.4Avg Vol 1M: 13,57,135.652W Range:₹87.15₹173.25
NSE BSE
₹162.48▼ 0.10%
Key Ratios
Updated 6h ago
Market Cap₹1,417 Cr
Current Price₹162.48
Previous Close₹162.64
High / Low (52w)₹173.25 / ₹87.15
Volume3,72,371
Avg Vol (1W)9,67,963.4
Avg Vol (1M)13,57,135.6
Stock P/E90.07
Book Value₹159.38
Dividend Yield0%
ROE3.6%
ROA2.5%
Revenue (TTM)₹643 Cr
Revenue Growth-67.1%
Profit Margin6.6%
Total Debt₹8 Cr
Shares Outstanding9 Cr
Face Value₹10
EPS (TTM)₹1.81
P/B1.02
Debt / Equity0.01
50 DMA₹143.03
200 DMA₹118.17
Day change-0.10%
Price Chart
₹162.48▲ 58.52% · 1Y
₹164₹881.3Cr
2025-06-17
2026-06-12

20-day avg volume: 13.6L shares

Pros
  • Company is almost debt-free.
Cons
  • Revenue fell 11% YoY.
  • Company is loss-making at the latest annual result.
  • Stock trades at a high P/E of 90.
Quarterly Results
MetricJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue₹33 Cr₹12 Cr₹129 Cr₹138 Cr₹153 Cr₹153 Cr₹151 Cr₹170 Cr
EBITDA₹1 Cr₹1 Cr₹4 Cr₹-12 Cr₹12 Cr₹12 Cr₹23 Cr₹15 Cr
Net Profit₹1 Cr₹0 Cr₹-5 Cr₹222 Cr₹9 Cr₹8 Cr₹10 Cr₹15 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹813 Cr₹914 Cr₹1,082 Cr₹1,241 Cr₹1,798 Cr₹643 Cr
EBITDA₹88 Cr₹118 Cr₹108 Cr₹205 Cr₹311 Cr₹38 Cr
Net Profit₹-21 Cr₹-3 Cr₹-2 Cr₹48 Cr₹539 Cr₹250 Cr
EPS——————
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹1,870 Cr₹1,818 Cr₹1,801 Cr₹1,824 Cr₹1,460 Cr₹1,438 Cr
Total Liabilities₹1,229 Cr₹1,215 Cr₹1,200 Cr₹1,142 Cr₹648 Cr₹265 Cr
Equity₹641 Cr₹603 Cr₹601 Cr₹682 Cr₹812 Cr₹1,173 Cr
Total Debt₹110 Cr₹82 Cr₹51 Cr₹744 Cr₹176 Cr₹8 Cr
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹125 Cr₹135 Cr₹150 Cr₹195 Cr₹-187 Cr₹-25 Cr
Investing₹-9 Cr₹-10 Cr₹5 Cr₹-13 Cr₹-27 Cr₹-110 Cr
Financing₹-133 Cr₹-124 Cr₹-141 Cr₹-186 Cr₹657 Cr₹69 Cr
Free Cash Flow₹125 Cr₹135 Cr₹150 Cr₹195 Cr₹-187 Cr₹-25 Cr

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search